Delta-Fly Pharma (TSE:4598) NonCurrent Deferred Liabilities: 円0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4598 Delta-Fly Pharma Inc TSE:4598
31 GF Score
Price 円101.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma NonCurrent Deferred Liabilities?

Delta-Fly Pharma TSE:4598 -2.88% 31 NonCurrent Deferred Liabilities is 円0.00 Mil as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Delta-Fly Pharma's non-current deferred liabilities for the quarter that ended in Mar. 2026 was 円0.00 Mil.

Delta-Fly Pharma NonCurrent Deferred Liabilities Related Terms

Delta-Fly Pharma NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma NonCurrent Deferred Liabilities Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Delta-Fly Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4598
31GF Score
Delta-Fly Pharma Inc TSE:4598
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of 円0.00 Mil mean?
Delta-Fly Pharma (TSE:4598) has a NonCurrent Deferred Liabilities of 円0.00 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Delta-Fly Pharma and its competitors.
Is Delta-Fly Pharma's NonCurrent Deferred Liabilities too high?
Delta-Fly Pharma's current NonCurrent Deferred Liabilities is 円0.00 Mil. Overall, Delta-Fly Pharma has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Delta-Fly Pharma's NonCurrent Deferred Liabilities of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Delta-Fly Pharma and its competitors. Delta-Fly Pharma's current NonCurrent Deferred Liabilities is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current NonCurrent Deferred Liabilities of 円0.00 Mil. The current NonCurrent Deferred Liabilities is 円0.00 Mil. Delta-Fly Pharma's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current NonCurrent Deferred Liabilities is 円0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
31GF Score

Get the complete analysis for TSE:4598

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円101.00
Price